April 24, 2013
The Society for Biological Engineering (SBE) has announced the formation of a new consortium of leading pharmaceutical and biotechnology companies to pursue new avenues in Chinese Hamster Ovary (CHO) cell line research. This new effort builds upon earlier cooperative work that successfully completed the sequencing and annotation of the Chinese hamster genome. The results could accelerate the process of drug discovery, while increasing the quality, consistency, and production efficiency of life-saving medicines...
Related Topics: